Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the OTC Drug And Dietary Supplement Market Heading Into 2029?

In the recent past, there has been swift expansion in the cell banking outsourcing market size. Projections indicate an escalation from $11.19 billion in 2024 to $12.86 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.0%. This significant growth during the historical period can be linked to factors such as the heightened occurrence of chronic diseases, a surge in government-driven initiatives, regulatory backing and guidelines, and a rise in the formulation of banking services.

The market size for cell banking outsourcing is projected to experience a swift surge in the immediate future. Its accelerating growth is expected to hit “$21.65 billion by 2029, expanding at a compound annual growth rate (CAGR) of 13.9%. The market’s growth in the forecast period can be linked to factors such as the increased use of cell-based products, heightened demand for monoclonal antibodies, and an uptick in the acceptance of stem cell therapies. Other contributing factors include a growing aging population and an increasing reliance on cell-based therapies. Key trends that are expected to shape the landscape of the market forecast period include product innovation, advancements in technology, increased investment in R&D, and strategic partnerships between biotech entities and specialized cell banking services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Factors Are Pushing The OTC Drug And Dietary Supplement Market Forward?

The OTC drug and dietary supplement market is anticipated to flourish due to an increase in pharma R&D spending. This investment pertains to the expenditure by a company on research, development, and improvement of its products. Higher spending could lead to more creative and productive design and formulation of OTC and dietary supplements. For example, Eurostat, a statistical office in Luxembourg under the European Union, reported in December 2023 that the R&D expenditure for the EU in 2022 amounted to €352 billion ($384.42 billion), a 6.34% increase from €331 billion ($361.48 billion) in the previous year. Hence, the growth in pharma R&D spending is propelling the OTC drug and dietary supplement market forward.

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Future Market Trends Are Projected For The OTC Drug And Dietary Supplement Industry?

Significant players in the cell banking outsourcing market are concentrating on the creation of technologically superior solutions, like single-cell potency characterization platforms, to deliver accurate and comprehensive analyses of each cell’s potency. These platforms or methodology combinations are engineered to evaluate and quantify the proficiency and functional aptitudes of isolated cells within a populace of cells. For example, in January 2024, an Italian biotech firm, Cellply Srl, unveiled its main product, VivaCyte, which is an end-to-end single-cell potency characterization platform that combines potency assessment and immunophenotyping to streamline cell therapy research and development. VivaCyte is a self-contained, fully automated platform with single-cell precision, built to condense development durations, expenses, and hazards by rapidly and exhaustively characterizing the sophisticated functionality and working mechanism of prospective cellular immunotherapies. This platform expedites the examination of numerous cell therapy candidates from a range of process alternatives against multiple target cancer cells, ensuring consistent immune cell evaluation and individual cell functional profiling in a fraction of the timeframe required by existing analytical instruments.

Which Organizations Are Driving Progress In The OTC Drug And Dietary Supplement Industry?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Region Is Expected To Experience The Highest Growth In The OTC Drug And Dietary Supplement Industry?

North America was the largest region in the cell banking outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model